Frank J. Wright has been appointed interim president of the Clinical Trials Distribution Business Unit at Marken. In this new role, Mr. Wright will continue to build the company’s distribution capability for drug product and kits from clients to depots and investigator sites around the world.  
 
Mr. Wright will be responsible for growing the business, enhancing the team and identifying possible investment opportunities. He will also assist in recruiting the permanent president of the business unit.
 
Mr. Wright joins the company with more than 40 years of experience in the pharmaceutical, chemical and healthcare industries. He has held executive positions with companies including ICI, GlaxoSmithKline, and ChiRex. Most recently Mr. Wright was chief operating officer of Aptuit, a service provider to the pharmaceutical industry.
 
“Frank is a very professional and proven leader in our industry,” said Wes Wheeler, Marken’s chief executive officer. “He has extensive experience in building businesses, both organically and through acquisitions. He has extensive contacts and a deep understanding of the logistics and supply chain aspect of our industry. I look forward to working closely with Frank as we continue to build our clinical trials distribution business.”